News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
logo final
Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma
Healthcare · Access to innovation · Innovative drugs
Partners - THERIVA BIOLOGICS S.L.
agarose bead
Agarose Bead Technologies expands facility to meet rising global demand for novel therapies market
Communication · Corporate
Agarose Bead Technologies has enhanced its Burgos facility by boosting its agarose resin production…
Partners - Agarose Bead Technologies (ABT)
ceo quibim
La IA ayuda a los radiólogos a detectar más del 90% de cáncer de próstata en España
Healthcare · Access to innovation
 Spanish company Quibim's QP-Prostate solution, which uses biopsy and MRI data for training,…
Partners - Quibim SL
arthex biotech
ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)
Healthcare · Innovative drugs
ATX-01 is the industry’s first anti-microRNA therapeutic to be investigated in DM1
Partners - ARTHEx Biotech
Oryzon sede
ORYZON announces formal grant of key European patent for vafidemstat
Healthcare · Innovative drugs · International · EU projects
For the treatment of aggression and social withdrawal. 
Partners - Oryzon Genomics
Ceo Apta Targets
"ApToll is an immune modulator to treat ischaemic stroke in the acute phase. We have successfully completed Phase 2a and will soon conduct Phase 2b. We are also testing ApToll for other indications”
Healthcare · Innovative drugs
David Segarra, an aptamer technology entrepreneur, co-founded aptaTargets in 2014 and has led the…
Partners - GENESIS Biomed
Aprobación ensayo citoquinas Peaches
AEMPS approves Peaches' clinical trial with selective secretomes to treat COVID-19-associated cytokine storm
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies
  Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will…
Partners - PEACHES BIOTECH S.L.
CEO de Peaches anunciando aprobación ensayo tormenta citoquinas
AEMPS approves Peaches clinical trial with selective secretomes to treat COVID-19-associated cytokine storm
Healthcare · Innovative drugs · Personalized medicine
Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will help combat…
Partners - PEACHES BIOTECH S.L.
Fecundis startup
Fecundis secures $2.4 million in seed funding
Healthcare · Access to innovation · Personalized medicine
This funding will allow the company -based in the Barcelona Science Parkspeed up the path to…
Partners - Parc Científic de Barcelona